ProteinQure Inc. | WebDisclosure

BRIEF

published on 12/06/2024 at 18:35, 15 days ago

ProteinQure to Unveil New Data on PQ203 at San Antonio Symposium

Clinical Trials Drug Development ProteinQure Breast Cancer PQ203
BRIEF

published on 12/06/2024 at 18:35, 15 days ago

ProteinQure dévoilera de nouvelles données sur PQ203 lors du symposium de San Antonio

Essais Cliniques Développement De Médicaments Cancer Du Sein PQ203 ProtéineQure
PRESS RELEASE

published on 12/06/2024 at 18:30, 15 days ago

ProteinQure to Present Data on PQ203, a Novel Peptide-Drug Conjugate for Triple Negative Breast Cancer, at 2024 San Antonio Breast Cancer Symposium
ProteinQure to present promising data on PQ203, a peptide drug conjugate for TNBC treatment, at 2024 San Antonio Breast Cancer Symposium. Phase 1 trial in 2025

Clinical Trials ProteinQure TNBC Breast Cancer PQ203
BRIEF

published on 03/25/2024 at 05:06, 8 months 27 days ago

ProteinQure Unveils Breakthrough Peptide Drug Conjugate for Triple-Negative Breast Cancer

ProteinQure TNBC PDX Models Computational Drug Design AACR Conference
BRIEF

published on 03/25/2024 at 05:06, 8 months 27 days ago

ProteinQure dévoile un conjugué peptidique-médicament révolutionnaire pour le cancer du sein triple négatif

TNBC ProtéineQuure Modèles PDX Conception Informatique De Médicaments Conférence AACR
PRESS RELEASE

published on 03/25/2024 at 05:01, 8 months 27 days ago

ProteinQure Announces A Breakthrough Therapeutic with Remarkable Efficacy in Heterogenous Patient-Derived Xenograft Models of Triple-Negative Breast Cancer to be presented at AACR
ProteinQure announces breakthrough in triple-negative breast cancer treatment through novel Peptide Drug Conjugate with exceptional efficacy in lab experiments

Clinical Trial ProteinQure Computational Drug Design Peptide Drug Conjugate Breast Cancer Treatment
PRESS RELEASE

published on 06/26/2023 at 17:10, 1 year 5 months ago

ProteinQure Inc. Announces Robust Preclinical Efficacy in a Triple Negative Breast Cancer Mouse Tumour Model Study

Published on 12/21/2024 at 01:30, 17 hours 26 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 26 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 18 hours 51 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 18 hours 56 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 26 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

Published on 12/21/2024 at 00:51, 18 hours 5 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 11 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 23 hours 46 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day ago

ARYZTA AG Announces New Board Technology Committee

View all EQS

Published on 12/21/2024 at 12:17, 6 hours 38 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 6 hours 38 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE

News